https://www.selleckchem.com/products/bay-3827.html
Finally, novel and promising areas of research will be highlighted, including the potential involvement of the NLRP3 inflammasome in mild TBI, how factors such as biological sex may affect NLRP3 activity in TBI, and the use of emerging biomarker platforms. Taken together, this review highlights the exciting potential of the NLRP3 inflammasome as a target for treatments and biomarkers that may ultimately be used to improve TBI management.BACKGROUND Chronic brain hypoperfusion (CBH) is closely related to Alzheimer's disease (AD) and vasc
Like
Comment
Share
